GlassScriptPhysician profile
Mary M Li
NPI 1275503971
$47,699.50
in general payments reported to CMS, 2019-2025
92 companies · $9,793 in 2025
The $9,793 reported for 2025 was more than what 80% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,687 · 2020: $5,938 · 2021: $2,018 · 2022: $7,195 · 2023: $5,935 · 2024: $7,133 · 2025: $9,793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,633 · Consulting Fee: $2,298 · Travel and Lodging: $1,902 · Education: $881 · Long Term Medical Supply Or Device Loan: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,465.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,633.33 |
| Consulting Fee | $2,298.00 |
| Travel and Lodging | $1,902.30 |
| Education | $880.76 |
| Long Term Medical Supply Or Device Loan | $681.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $7,231.24 | 2019-2025 | Reblozyl, Pomalyst |
| Astrazeneca Pharmaceuticals LP | $6,257.65 | 2019-2025 | Imfinzi, Lynparza, Enhertu |
| Avyxa Pharma, LLC | $4,976.43 | 2025 | |
| Janssen Biotech, INC. | $4,397.40 | 2019-2025 | Rybrevant, Erleada, Carvykti |
| Eisai INC. | $3,445.23 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $2,361.50 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Novartis Pharmaceuticals Corporation | $1,612.47 | 2019-2025 | Piqray, Kisqali |
| Genzyme Corporation | $1,436.54 | 2019-2025 | |
| Cti Biopharma Corp. | $1,099.11 | 2022-2023 | Vonjo |
| Pfizer INC. | $1,008.51 | 2019-2025 | |
| Seagen INC. | $815.31 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Beigene USA, INC. | $769.73 | 2020-2025 | Brukinsa, Tevimbra |
| Merck Sharp & Dohme LLC | $695.36 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Astellas Pharma US INC | $640.64 | 2019-2025 | Padcev, Xtandi, Vyloy |
| Genentech USA, INC. | $575.51 | 2019-2025 | Tecentriq, Polivy, Venclexta |
Show all 92 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $550.76 | 2019-2025 | Jakafi, Monjuvi |
| Glaxosmithkline, LLC. | $521.85 | 2020-2025 | Zejula, Jemperli, Ojjaara |
| Abbvie INC. | $496.28 | 2020-2025 | |
| Amgen INC. | $483.58 | 2019-2023 | Lumakras |
| Pharmacyclics LLC, An Abbvie Company | $468.99 | 2019-2023 | Imbruvica |
| Gilead Sciences, INC. | $429.26 | 2021-2025 | Trodelvy |
| Daiichi Sankyo INC. | $415.94 | 2019-2025 | Enhertu, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $390.95 | 2019-2025 | |
| Puma Biotechnology, INC. | $388.02 | 2022-2025 | Nerlynx |
| Regeneron Healthcare Solutions, INC. | $350.06 | 2021-2025 | Libtayo |
| Beone Medicines USA, INC. | $314.33 | 2025 | Brukinsa, Tevimbra |
| G1 Therapeutics, INC. | $269.27 | 2022-2023 | Cosela |
| Rigel Pharmaceuticals, INC. | $238.29 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Karyopharm Therapeutics INC. | $237.48 | 2020-2025 | Xpovio |
| Kite Pharma, INC. | $232.29 | 2021-2025 | Yescarta |
| Mirati Therapeutics, INC. | $223.41 | 2023-2024 | Krazati |
| Aveo Pharmaceuticals, INC. | $211.64 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $207.17 | 2019-2025 | |
| Array Biopharma INC | $193.18 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Aurobindo Pharma USA, INC. | $176.39 | 2019-2020 | |
| Genmab U.S., INC. | $173.37 | 2023-2024 | Epkinly |
| Taiho Oncology, INC. | $164.27 | 2019-2025 | |
| Sobi, INC | $157.73 | 2022-2024 | |
| Blueprint Medicines Corporation | $145.26 | 2020-2025 | Ayvakit |
| Clovis Oncology, INC. | $145.22 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.99 | 2019-2024 | Alunbrig |
| Phathom Pharmaceuticals, INC. | $130.00 | 2024 | Voquezna |
| Dendreon Pharmaceuticals LLC | $129.89 | 2021-2025 | Provenge |
| Ethicon INC. | $124.30 | 2022 | |
| Csl Behring | $124.07 | 2020-2025 | Afstyla, Idelvion |
| Emd Serono, INC. | $112.67 | 2019-2025 | Bavencio |
| Pharmacosmos Therapeutics INC. | $111.05 | 2023-2024 | Cosela, Monoferric |
| Octapharma USA, INC. | $109.77 | 2020 | |
| Stemline Therapeutics INC. | $102.32 | 2023-2024 | Orserdu |
| Kyowa Kirin, INC. | $94.54 | 2020-2025 | Poteligeo |
| Lilly USA, LLC | $91.55 | 2019-2024 | Verzenio, Jaypirca |
| Myovant Sciences INC. | $87.39 | 2021-2022 | |
| Epizyme, INC. | $84.19 | 2021 | |
| Servier Pharmaceuticals LLC | $75.67 | 2023-2024 | |
| Agios Pharmaceuticals, INC. | $73.19 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $72.03 | 2021-2024 | |
| Deciphera Pharmaceuticals INC. | $70.81 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $69.71 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $66.18 | 2020-2023 | Somatuline Depot, Onivyde |
| Pharmaessentia USA Corporation | $64.74 | 2023-2025 | Besremi |
| Legend Biotech USA INC. | $62.98 | 2025 | Carvykti |
| Tesaro, INC. | $53.78 | 2019 | |
| Dova Pharmaceuticals | $44.50 | 2019-2021 | |
| Acceleron Pharma, INC. | $44.04 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $43.33 | 2019 | |
| Alexion Pharmaceuticals, INC. | $38.41 | 2021-2025 | Ultomiris |
| Ge Healthcare | $38.39 | 2022 | |
| Exelixis INC. | $36.40 | 2022-2023 | Cabometyx |
| Alnylam Pharmaceuticals INC. | $33.81 | 2022-2023 | Givlaari |
| Adc Therapeutics America, INC. | $32.42 | 2022 | |
| Global Blood Therapeutics, INC. | $31.04 | 2020-2022 | |
| Recordati_rare_diseases_inc. | $30.87 | 2025 | Enjaymo |
| Tg Therapeutics, INC. | $28.28 | 2021 | |
| Acrotech Biopharma INC. | $28.26 | 2024 | Ryzneuta |
| Immunocore Limited | $27.26 | 2025 | Kimmtrak |
| Novocure INC. | $24.74 | 2025 | Optune Gio |
| Telix Pharmaceuticals | $24.16 | 2025 | Illuccix |
| Eusa Pharma (US) LLC | $23.29 | 2022 | |
| Adaptive Biotechnologies Corporation | $22.00 | 2022 | |
| Medtronic, INC. | $21.47 | 2025 | Intellis Adaptivestim |
| Geron Corporation | $20.88 | 2025 | Rytelo |
| Sumitomo Pharma America, INC. | $18.11 | 2024 | Orgovyx |
| Amag Pharmaceuticals, INC. | $18.10 | 2019 | |
| Partner Therapeutics, INC. | $16.68 | 2019 | |
| Heron Therapeutics, INC. | $15.95 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $15.73 | 2019 | |
| Azurity Pharmaceuticals, INC. | $15.04 | 2025 | Danziten |
| Sirtex Medical INC | $14.09 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.97 | 2020 | |
| Advanced Accelerator Applications | $11.96 | 2020 | |
| Veracyte, INC. | $9.90 | 2020 | |
| Secura Bio, INC. | $7.98 | 2020 |
Drugs and devices associated with these payments
Imfinzi $1,843Reblozyl $1,627Kisqali $763Sarclisa $646Lenvima $600Opdivo $561Brukinsa $548Keytruda $459Inlyta $398Imbruvica $371Libtayo $330Epkinly $310Lynparza $282Enhertu $280Tukysa $279Krazati $258Adcetris $254Padcev $254Nerlynx $235Pluvicto $231Elrexfio $231Tavalisse $221Rezlidhia $221Rybrevant $220Jakafi $214Pomalyst $206Zejula $179Carvykti $169Xpovio $162Jemperli $159Trodelvy $153Tevimbra $153Fotivda $149Cosela $147Bosulif $145Monjuvi $139Erleada $135Voquezna $130Fabhalta $126Braftovi $125Xofigo $120Nubeqa $120Provenge $116Ojjaara $112Mektovi $104Vonjo $103Orserdu $102Ibrance $102Doptelet $99.95Gavreto $90.35Venclexta $85.85Lorbrena $82.01Lutathera $80.67Xtandi $78.78Alunbrig $77.15Tibsovo $75.67Tecentriq $75.38Odomzo $69.71Yonsa $69.71Poteligeo $68.93Besremi $64.74Yescarta $61.10Idhifa $57.32Opdualag $52.89Illuccix $48.32Piqray $47.02Inqovi $46.62Lonsurf $46.62Talzenna $44.20Afstyla $43.77Idelvion $43.77Enjaymo $43.13Orgovyx $42.89Darzalex $41.39Tivdak $38.63Jevtana $37.69Tecvayli $36.14Emrelis $35.19Verzenio $33.81Zepzelca $33.76Mekinist $32.01Blenrep $31.85Scemblix $30.30Xalkori $29.77Keytruda Qlex $28.55Ryzneuta $28.26Kimmtrak $27.26Polivy $25.11Comirnaty $24.78Optune Gio $24.74Ultomiris $23.62Talvey $23.29Elitek $22.26Intellis Adaptivestim $21.47Datroway $21.22Monoferric $21.03Rytelo $20.88Jaypirca $18.65Bavencio $18.10Ayvakit $17.72
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.